van den Besselaar A M, Ram I E, Alderkamp G H, Bertina R M
Thromb Haemost. 1982 Aug 24;48(1):54-8.
Tissue thromboplastin apoprotein was partially purified from human brain. The apoprotein was recombined with mixed phospholipids to yield active thromboplastin. The recombined thromboplastin induced proteolytic activation of isolated human factor IX in the presence of factor VII and Ca2+. The clotting times of various deficient plasmas were determined as a function of apoprotein concentration, keeping the phospholipid concentration constant. The clotting times of a factor XII-deficient plasma were the same as those of a factor XII/factor IX-deficient plasma, except at very low apoprotein concentrations. However, under those conditions the difference in clotting times was independent of the presence of anti-factor VII serum. Similar observations were made for factor XI-deficient plasma in comparison with factor XI/factor IX-deficient plasma. These results indicate that activation of factor IX by factor VII/tissue thromboplastin does not significantly contribute to plasma coagulation.
从人脑中部分纯化组织凝血活酶载脂蛋白。该载脂蛋白与混合磷脂重组以产生活性凝血活酶。在因子VII和Ca2+存在的情况下,重组凝血活酶诱导分离的人因子IX的蛋白水解激活。在保持磷脂浓度恒定的情况下,测定各种缺陷血浆的凝血时间作为载脂蛋白浓度的函数。除了在非常低的载脂蛋白浓度下,因子 XII 缺陷血浆的凝血时间与因子 XII/因子 IX 缺陷血浆的凝血时间相同。然而,在这些条件下,凝血时间的差异与抗因子 VII 血清的存在无关。与因子 XI/因子 IX 缺陷血浆相比,因子 XI 缺陷血浆也有类似的观察结果。这些结果表明,因子 VII/组织凝血活酶对因子 IX 的激活对血浆凝血没有显著贡献。